GO:0008289 lipid binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008289 lipid binding is a molecular function defined as binding to a lipid, encompassing reversible and covalent interactions with fatty acids, phospholipids, sterols, sphingolipids and other lipid species.
• Lipid binding underlies membrane anchoring, autophagy, integrin activation, WNT secretion and lysosomal lipid handling, making it central to cell biology and disease [1,4,6,7].
• Representative lipid-binding proteins include ATG16L1, LC3C, TRIM72, talin (TLN1), APOE and WNT morphogens, each with distinct lipid specificity and regulatory roles [1,2,4,6,7,8].
• Protein-lipid conjugation, such as lipidation of LC3-family proteins, is a specialized form of lipid binding that directly controls autophagosome formation [3,8].
• Dysregulated lipid binding contributes to neurodegeneration, cancer, metabolic disease and antifungal drug delivery challenges [1,5,7].
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal dissection of lipid-binding domains and their disease relevance [1,4,6].
Description
Lipid binding (GO:0008289) is a molecular function describing the binding to a lipid, a broad activity that includes non-covalent recognition of lipid headgroups or acyl chains as well as covalent protein-lipid conjugation. Lipids are not merely structural components of membranes; they serve as signaling molecules, membrane anchors and cargo, and proteins that bind them are essential for processes ranging from autophagy to morphogen secretion [3,6,7]. The QuickGO definition of GO:0008289 is deliberately broad, reflecting the chemical diversity of lipids and the many protein folds that have evolved to recognize them. For researchers, lipid binding is a convergence point between membrane biology, metabolism and signal transduction. For example, the autophagy protein ATG16L1 possesses intrinsic lipid-binding activity that supports efficient membrane anchoring during autophagosome formation, while LC3C binds phospholipids and interacts with lipid membranes to execute autophagic functions. In the immune and muscle context, TRIM72 exhibits lipid-binding properties that contribute to membrane repair and signaling. Lipid binding also governs integrin activation through the talin F1 domain, where a lipid-dependent helix works in tandem with Rap1 binding. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to provide a research-grade overview of GO:0008289 lipid binding, including its mechanistic basis, key genes, disease links and experimental strategies. All statements are grounded in the cited primary literature, and the content is structured for both human readers and generative-AI retrieval systems.
lipid binding At A Glance
| GO ID | GO:0008289 |
|---|---|
| GO term | lipid binding |
| Ontology | molecular_function |
| Synonym | none listed |
| Definition | Binding to a lipid. |
| Major function | Recognition and interaction with lipid molecules, including membrane anchoring, lipid transport and protein-lipid conjugation [3,6,8] |
| Representative proteins | ATG16L1, LC3C, TRIM72, TLN1 (talin), APOE, WNT morphogens [1,2,4,6,7,8] |
| Related processes | Autophagy, integrin activation, WNT secretion, lysosomal lipid handling, membrane repair [1,4,6,7] |
| Disease relevance | Neurodegeneration, cancer, metabolic disorders, antifungal delivery [1,5,7] |
What Is GO:0008289?
In your own words, GO:0008289 lipid binding is the molecular function of selectively and non-covalently or covalently interacting with a lipid molecule. This includes binding to fatty acids, phospholipids, sterols, sphingolipids, glycerolipids and other lipid classes, and it may occur at membrane surfaces, within lipid bilayers, or in the context of protein-lipid conjugation such as lipidation. The term does not specify a particular lipid or protein family; instead, it captures the common activity of recognizing lipid species to execute biological roles including membrane anchoring, cargo transport, signaling and structural organization [3,6,8].
Why Is lipid binding Important in Cell Biology?
Lipid binding is important because lipids are ubiquitous and functionally diverse, and proteins that bind them control fundamental cellular processes such as membrane remodeling, autophagy, signal transduction and cargo secretion [3,6,7]. Disruption of lipid binding can alter protein localization, stability and activity, leading to disease phenotypes including neurodegeneration and cancer [1,7]. Moreover, understanding lipid binding informs drug delivery strategies, as shown by lipid-modified chitin-binding domains that enhance antifungal activity.
• Lipid binding enables proteins to associate with membranes, which is essential for autophagy, vesicle trafficking and signal transduction [3,6,8].
• Protein-lipid conjugation, a specialized lipid-binding mechanism, directly regulates autophagosome formation and cargo selection [3,8].
• Lipid binding by ATG16L1 supports efficient membrane anchoring during autophagy, linking lipid recognition to cellular homeostasis.
• LC3C binding to phospholipids and interaction with lipid membranes are critical for autophagic membrane dynamics.
• TRIM72 lipid-binding properties contribute to membrane repair and muscle physiology.
• The talin F1 domain uses a lipid-dependent helix together with Rap1 binding to promote integrin activation, connecting lipid binding to cell adhesion.
• APOE lipidation and receptor interactions influence lysosomal lipid cargo handling and pathogenicity, with implications for neurodegeneration.
• WNT morphogens require lipid-dependent secretion and delivery, highlighting lipid binding in developmental signaling.
• Lipid-modified chitin-binding domains improve antifungal drug formulations, demonstrating translational applications of lipid binding.
• Dysregulated lipid binding is implicated in cancer, metabolic disease and neurodegeneration, making it a therapeutic target area [1,7].
Molecular Mechanism of lipid binding
Lipid recognition and binding specificity
In simple terms: Proteins have pockets or surfaces that fit specific lipids, like a lock and key.
Lipid binding begins with molecular recognition of a lipid species by a protein domain or motif. The chemical diversity of lipids, including variations in headgroup, acyl chain length and saturation, allows proteins to discriminate among lipid classes. For example, LC3C binds phospholipids and interacts with lipid membranes, demonstrating specificity for membrane lipids. TRIM72 also exhibits lipid-binding properties, indicating that distinct protein folds can recognize lipids in different contexts. This recognition step is often driven by hydrophobic and electrostatic interactions, and it can be modulated by membrane curvature and lipid packing.
Membrane anchoring and insertion
In simple terms: After grabbing a lipid, the protein inserts itself into the membrane to stay attached.
Once a lipid is recognized, many proteins anchor themselves into the membrane via hydrophobic insertion or amphipathic helices. ATG16L1 has intrinsic lipid-binding activity that supports efficient membrane anchoring during autophagy, allowing it to localize to forming autophagosomes. Similarly, the talin F1 domain contains a lipid-dependent helix that promotes integrin activation in tandem with Rap1 binding, illustrating how membrane insertion is coupled to signaling. This anchoring step is critical for spatial organization of cellular processes.
Protein-lipid conjugation and lipidation
In simple terms: Some proteins are chemically glued to lipids, which changes how they work.
A specialized form of lipid binding is protein-lipid conjugation, where a lipid is covalently attached to a protein. This process, known as lipidation, is central to autophagy: LC3-family proteins are conjugated to phosphatidylethanolamine, enabling them to associate with autophagosomal membranes [3,8]. Cell biology of protein-lipid conjugation reveals that this modification is reversible and tightly regulated, affecting protein localization and function. Such conjugation expands the functional repertoire of lipid binding beyond non-covalent interactions.
Lipid-dependent cargo transport and secretion
In simple terms: Lipid binding helps move cargo, like WNT proteins, out of cells.
Lipid binding also mediates the transport and secretion of lipid-modified cargo. WNT morphogens require lipid-dependent secretion, delivery and activity, and extracellular carriers control these processes. APOE lipidation influences its interactions with receptors and its lipid cargoes in lysosomes, with decreased lipidated ApoE-receptor interactions conferring protection against pathogenicity. These examples show that lipid binding is not only structural but also instructive for intercellular communication [1,7].
Regulation by cofactors and signaling
In simple terms: Other proteins and signals can turn lipid binding on or off.
Lipid binding is regulated by cofactors, post-translational modifications and signaling events. For instance, Rap1 binding and a lipid-dependent helix in the talin F1 domain act in tandem to promote integrin activation, indicating that lipid binding is integrated with small GTPase signaling. In autophagy, the conjugation of LC3 proteins to lipids is controlled by enzymatic cascades that are responsive to cellular stress [3,8]. These regulatory layers ensure that lipid binding occurs at the right time and place [3,4].
Key Genes Involved in GO:0008289 lipid binding
The following genes encode proteins with demonstrated lipid-binding activity or roles in lipid-binding processes, as supported by the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATG16L1 | Intrinsic lipid-binding activity for membrane anchoring in autophagy | Autophagy regulation and Crohn's disease models |
| LC3C | Phospholipid binding and interaction with lipid membranes | Autophagosome formation and cancer |
| TRIM72 | Lipid-binding properties in membrane repair | Muscle physiology and membrane integrity |
| TLN1 (talin) | Lipid-dependent helix in F1 domain promotes integrin activation | Cell adhesion and integrin signaling |
| APOE | Lipidation and receptor interactions in lysosomal lipid cargo | Neurodegeneration and lipid metabolism |
| WNT family | Lipid-dependent secretion, delivery and activity | Developmental signaling and cancer |
| MAP1LC3B | Lipidation for autophagosome association | Autophagy flux and disease models |
| GABARAP | Protein-lipid conjugation in autophagy | Autophagy and membrane trafficking |
| ATG7 | Enzyme for LC3 lipidation | Autophagy pathway dissection |
| ATG3 | Enzyme for LC3 lipidation | Autophagy and lipid conjugation |
| RAP1A | Small GTPase cooperating with talin lipid-dependent helix | Integrin activation |
| APOE4 | Lipidated ApoE-receptor interactions | Alzheimer's disease risk |
| WNT3A | Lipid-dependent secretion | WNT signaling and cancer |
| WNT5A | Lipid-dependent secretion | Developmental morphogenesis |
| CHIT1 | Chitin-binding domain modified with lipids | Antifungal drug delivery |
| SQSTM1 | Lipid binding in selective autophagy | Autophagy and cancer |
| NBR1 | Lipid binding in selective autophagy | Autophagy and cancer |
How Is lipid binding Regulated?
Lipid binding is regulated at multiple levels. Protein-lipid conjugation, such as LC3 lipidation, is controlled by enzymatic cascades involving ATG7 and ATG3, which are responsive to cellular stress and nutrient status. In integrin activation, Rap1 binding and a lipid-dependent helix in the talin F1 domain act in tandem, integrating small GTPase signaling with lipid recognition. Additionally, extracellular carriers control lipid-dependent secretion of WNT morphogens, indicating that the extracellular environment can regulate lipid binding and delivery. These regulatory mechanisms ensure that lipid binding is spatially and temporally controlled [3,4,7].
lipid binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| APOE | Neurodegeneration, Alzheimer's disease | Knock-in mice expressing human APOE variants |
| ATG16L1 | Crohn's disease, autophagy dysfunction | Knockout intestinal organoids |
| LC3C | Cancer, autophagy dysregulation | Knockout cancer cell lines |
| TRIM72 | Muscle membrane repair disorders | Knockout myoblasts |
| WNT3A | Cancer, developmental disorders | Overexpression in reporter cell lines |
Neurodegeneration and APOE lipidation
APOE lipidation and its interactions with receptors in lysosomes are linked to pathogenicity of ApoE and its lipid cargoes. Decreased lipidated ApoE-receptor interactions confer protection against pathogenicity, suggesting that lipid binding by APOE is a critical determinant of neurodegeneration risk. This has implications for Alzheimer's disease and other tauopathies where lipid handling is impaired.
Cancer and WNT signaling
WNT morphogens require lipid-dependent secretion, delivery and activity, and extracellular carriers control these processes. Dysregulation of WNT lipid binding can lead to aberrant signaling in cancer, making components of this pathway potential therapeutic targets. Additionally, autophagy-related lipid binding proteins such as LC3C and ATG16L1 influence cancer cell survival and stress responses [6,8].
Metabolic and membrane repair disorders
TRIM72 lipid-binding properties are important for membrane repair, and defects in this process can contribute to muscle disorders. Lipid binding by proteins such as ATG16L1 also affects metabolic homeostasis through autophagy, linking lipid recognition to metabolic disease. Furthermore, lipid-modified chitin-binding domains have been explored to enhance antifungal drug delivery, highlighting the translational relevance of lipid binding in infectious disease.
From lipid binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of lipid binding affect autophagy flux? | ATG16L1 or LC3C knockout cell lines [6,8] |
| How does a point mutation in a lipid-binding domain alter integrin activation? | TLN1 point-mutation knock-in cells |
| Can lipid binding be visualized in live cells? | Tagged knock-in of LC3C or ATG16L1 with fluorescent protein [6,8] |
| Does overexpression of APOE variants change lipid cargo handling? | APOE overexpression in neuronal cell lines |
| What is the role of lipid binding in WNT secretion? | WNT3A overexpression and secretion assays |
| Can lipid-modified domains enhance drug delivery? | Chitin-binding domain lipid modification in fungal assays |
How to Study the lipid binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lipid overlay assay | Direct binding to specific lipids | Determining lipid specificity of TRIM72 |
| Liposome binding assay | Binding to lipid membranes | LC3C phospholipid interaction |
| Fluorescence microscopy | Subcellular localization and membrane association | ATG16L1 membrane anchoring |
| Biochemical fractionation | Membrane-bound vs cytosolic protein | LC3 lipidation analysis |
| Lipidation assay | Covalent protein-lipid conjugation | Autophagy flux measurement [3,8] |
| CRISPR knockout screen | Genes required for lipid binding processes | Autophagy regulator discovery |
| Secreted reporter assay | Lipid-dependent secretion | WNT morphogen delivery |
| Lipid-modified drug assay | Enhanced antifungal activity | Chitin-binding domain formulation |
Lipid overlay and binding assays
Lipid overlay assays and liposome binding assays are used to determine the lipid specificity of proteins such as TRIM72 and LC3C [2,8]. These methods measure direct binding to immobilized lipids or lipid vesicles and can be combined with mutagenesis to map binding domains [2,8].
Fluorescence microscopy and imaging
Fluorescence microscopy of tagged proteins, such as GFP-LC3C or ATG16L1, allows visualization of membrane association and autophagosome formation in live cells [6,8]. Co-localization with lipid markers provides spatial information about lipid binding.
Biochemical fractionation and lipidation assays
Biochemical fractionation separates membrane-bound from cytosolic proteins, and lipidation assays detect covalent lipid conjugation of LC3-family proteins [3,8]. These techniques are essential for studying protein-lipid conjugation and membrane anchoring.
CRISPR-based genetic screens
CRISPR knockout screens can identify genes required for lipid binding-dependent processes such as autophagy and WNT secretion [6,7]. Pooled screens with lipid-binding reporters enable unbiased discovery of regulators [6,7].
How CRISPR Can Be Used to Study GO:0008289 lipid binding
Knockout
CRISPR knockout of lipid-binding genes such as ATG16L1 or LC3C enables loss-of-function studies to determine their role in autophagy and membrane dynamics [6,8]. Knockout cell lines can be used to assess changes in lipid binding, membrane anchoring and downstream signaling [6,8].
Point Mutation
Point mutations in lipid-binding domains, such as the talin F1 lipid-dependent helix, can be introduced to dissect specific residues required for lipid interaction and integrin activation. These models help distinguish lipid binding from other protein functions.
Knock-in
Knock-in of tagged versions of lipid-binding proteins, such as fluorescently labeled LC3C or ATG16L1, allows real-time imaging of lipid binding and membrane recruitment in physiological contexts [6,8]. Knock-in of disease-associated variants, such as APOE alleles, can model altered lipid binding in neurodegeneration.
Overexpression
Overexpression of lipid-binding proteins like WNT3A or APOE can be used to study lipid-dependent secretion and cargo handling [1,7]. Overexpression systems are useful for biochemical purification and lipid binding assays [1,7].
How EDITGENE Supports lipid binding Research
Researchers studying lipid binding-related genes often need to determine whether a candidate gene is causally involved in lipid recognition, membrane anchoring or downstream signaling. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models that enable such causal studies.
Contact EDITGENE today to design your custom CRISPR model for lipid binding research.
Frequently Asked Questions About lipid binding
What is GO:0008289 lipid binding?
GO:0008289 lipid binding is a molecular function defined as binding to a lipid, encompassing non-covalent and covalent interactions with fatty acids, phospholipids, sterols and other lipid species.
What genes are involved in lipid binding?
Key genes include ATG16L1, LC3C, TRIM72, TLN1, APOE and WNT family members, each with distinct lipid-binding roles [1,2,4,6,7,8].
How is lipid binding studied experimentally?
Common methods include lipid overlay assays, liposome binding assays, fluorescence microscopy, biochemical fractionation and CRISPR screens [2,3,6,8].
Why is lipid binding important in autophagy?
Lipid binding by ATG16L1 and LC3C supports membrane anchoring and autophagosome formation, which are essential for autophagy [6,8].
What diseases are linked to lipid binding defects?
Neurodegeneration, cancer, metabolic disorders and membrane repair disorders have been linked to altered lipid binding [1,2,6,7].
How does APOE lipid binding affect Alzheimer's disease?
Decreased lipidated ApoE-receptor interactions confer protection against pathogenicity of ApoE and its lipid cargoes in lysosomes, implicating lipid binding in neurodegeneration.
Can CRISPR be used to study lipid binding?
Yes, CRISPR knockout, point mutation, knock-in and overexpression models enable precise dissection of lipid-binding domains and their functions [1,4,6,8].
What is protein-lipid conjugation?
Protein-lipid conjugation is a covalent form of lipid binding, such as LC3 lipidation, that regulates protein localization and autophagy [3,8].
Which proteins bind phospholipids?
LC3C binds phospholipids and interacts with lipid membranes, and ATG16L1 has intrinsic lipid-binding activity [6,8].
How does lipid binding affect WNT signaling?
WNT morphogens require lipid-dependent secretion, delivery and activity, and extracellular carriers control these processes.
Conclusion
GO:0008289 lipid binding is a fundamental molecular function that underpins membrane anchoring, autophagy, integrin activation, lipid cargo transport and morphogen secretion [3,4,6,7,8]. The diversity of lipid-binding proteins, from ATG16L1 and LC3C to TRIM72, talin, APOE and WNT, highlights the broad biological and disease relevance of this activity [1,2,4,6,7,8]. Understanding lipid binding mechanisms offers opportunities for therapeutic intervention in neurodegeneration, cancer and metabolic disorders [1,5,7]. By leveraging CRISPR-based knockout, point-mutation, knock-in and overexpression models, researchers can causally test the role of lipid-binding domains in health and disease. EDITGENE provides end-to-end services to generate these models and support discovery in lipid biology.
References
- 1. Guo JL et al.. 2025. Decreased lipidated ApoE-receptor interactions confer protection against pathogenicity of ApoE and its lipid cargoes in lysosomes.. Cell 188(1):187-206.e26 PMID: 39532095
- 2. Kim S et al.. 2012. Lipid-binding properties of TRIM72.. BMB Rep 45(1):26-31 PMID: 22281009
- 3. Sakamaki JI et al.. 2023. Cell biology of protein-lipid conjugation.. Cell Struct Funct 48(1):99-112 PMID: 37019684
- 4. Gingras AR et al.. 2019. Rap1 binding and a lipid-dependent helix in talin F1 domain promote integrin activation in tandem.. J Cell Biol 218(6):1799-1809 PMID: 30988001
- 5. Taniguchi H et al.. 2022. Liposomal Amphotericin B Formulation Displaying Lipid-Modified Chitin-Binding Domains with Enhanced Antifungal Activity.. Mol Pharm 19(11):3906-3914 PMID: 36066555
- 6. Dudley LJ et al.. 2019. Intrinsic lipid binding activity of ATG16L1 supports efficient membrane anchoring and autophagy.. EMBO J 38(9) PMID: 30936093
- 7. de Almeida Magalhaes T et al.. 2024. Extracellular carriers control lipid-dependent secretion, delivery, and activity of WNT morphogens.. Dev Cell 59(2):244-261.e6 PMID: 38154460
- 8. Ballesteros U et al.. 2022. Autophagy protein LC3C binding to phospholipid and interaction with lipid membranes.. Int J Biol Macromol 212:432-441 PMID: 35618088
